Abstract: A large format table-top cutting apparatus includes a cutter bar assembly configured to in use support and guide a cutting head to cut material located below the cutter bar assembly; a lifting mechanism configured to raise and lower the cutter bar assembly between an upper position and a lower position The cutter bar assembly includes an elongate upper and lower supports connected by a link assembly so that these are arranged substantially parallel to one another and can move relative to one another along their longitudinal axes, and a raising assembly configured for adjustment by a user to exert a variable force on the lower part of the upper support at one end so as to place the upper support in tension and raise the free-hanging central portion of the upper support.

Abstract: A large format table-top cutting apparatus includes a cutter bar assembly configured to in use support and guide a cutting head to cut material located below the cutter bar assembly; a lifting mechanism configured to raise and lower the cutter bar assembly between an upper position and a lower position The cutter bar assembly includes an elongate upper and lower supports connected by a link assembly so that these are arranged substantially parallel to one another and can move relative to one another along their longitudinal axes, and a raising assembly configured for adjustment by a user to exert a variable force on the lower part of the upper support at one end so as to place the upper support in tension and raise the free-hanging central portion of the upper support.

Abstract: Methods of detecting or predicting the presence of CRC based on the amounts of particular miRNAs in plasma or tissue are described.

Abstract: The present invention relates to a compound with the core structure of formula (I), or pharmaceutically acceptable salts or esters, solvates, or prodrugs thereof, for use in the treatment of cognitive impairment in a mammal. The compound is preferably isosteviol or steviol, or pharmaceutically acceptable salts or esters, solvates, or prodrugs thereof.

Abstract: Methods of detecting or predicting the presence of CRC based on the amounts of particular miRNAs in plasma or tissue are described.

Abstract: A light emitting diode (LED) lighting fixture for achieving a desired illumination pattern includes a panel and one or more LEDs attached to a surface of the panel. One or more of the LEDs may be mounted at an angle to the surface.

Abstract: A light emitting diode (LED) lighting fixture for achieving a desired illumination pattern includes a panel and one or more LEDs attached to a surface of the panel. One or more of the LEDs may be mounted at an angle to the surface.

Abstract: A light emitting diode (LED) lighting fixture for achieving a desired illumination pattern includes a panel and one or more LEDs attached to a surface of the panel. One or more of the LEDs may be mounted at an angle to the surface.

Abstract: A light emitting diode (LED) lighting fixture for achieving a desired illumination pattern includes a panel and one or more LEDs attached to a surface of the panel. One or more of the LEDs may be mounted at an angle to the surface.

Abstract: This invention relates to a method for the treatment of molten metal by introduction of a reactive additive and particularly to the treatment of molten iron by introduction of a nodularizer. The molten metal is introduced into a reaction chamber through one or more slots formed in one or more sides of the chamber thereby producing a cascade of molten metal which flows downwardly into the chamber. The reactive additive is added above the cascade and is rapidly drawn under the molten metal by the flow of the cascade.